what is tirzepatide used to treat for? Approved and Potential Uses Tirzepatide (Zepbound, Mounjaro): Weight Loss,

Figure 2 (B) data are shown from ( Nevertheless, GI complaints are the main adverse-event related cause of drug discontinuation in the phase-3 trials, with rates up to 12% ( Table 2 )

Most insurance plans cover Ozempic for its FDA-approved indications (such as type diabetes) and require a prior authorization (PA), while coverage for weight loss use is limited

GIPR/GLP-1R co-agonism has already proved efficient in clinical trials in obesity

Studies suggest this medication can lead to notable fat loss by helping control appetite, improving metabolism, and altering hormones that affect energy storage and usage

FDA Restrictions on Compound GLP-1 Medications This regulatory action follows the FDA's February 2025 declaration that the semaglutide shortage is officially "resolved." For compounded tirzepatide (Zepbound), the deadline was earlier - March 2025